XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding XBiotech Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 41 | 39 | −2 |
| Shares | 2.76M | 2.45M | −312.0K (−11.3%) |
| Value | $9.68M | $8.61M | −$1.07M (−11.0%) |
New holders (3)
Institutions that held XBiotech Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 38,163 | $131.7K | 0.00% |
| TD Waterhouse Canada Inc. | 200 | $928 | 0.00% |
| Simplex Trading, LLC | 85 | $0 | 0.00% |
Sold out (5)
Institutions that held XBiotech Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 137,174 | $481.5K |
| D. E. Shaw & Co., Inc. | 15,052 | $52.8K |
| HRT Financial LP | 13,279 | $46.0K |
| Trexquant Investment LP | 12,985 | $45.6K |
| IFP Advisors, Inc | 200 | $1.00K |